Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.40 0.00 (-0.36%)
As of: Nov 10, 2026 · 3:14 PM EST

Tvardi Therapeutics (TVRD) Raw Materials (2021 - 2022)

Updated

Tvardi Therapeutics (TVRD) reported Raw Materials of $1.83 million for Q3 2022, up 0.7% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Raw Materials (2021 - 2022) Analysis & Trends

At the end of FY2021, Tvardi Therapeutics posted Raw Materials of $927,000.

  • Per Business Quant data, the three quarters before Q3 2022 came in at $1.82 million (Q2 2022), $1.1 million (Q1 2022) and $927,000 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Tvardi Therapeutics 12.48 Mn -95.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 1.83 Mn
Jun 30, 2022 1.82 Mn
Mar 31, 2022 1.10 Mn
Dec 31, 2021 927,000.00
API Access

Tvardi Therapeutics Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=TVRD&period=max&api_key=YOUR_API_KEY